A nationwide 2010-2012 analysis of U.S. health care utilization in inflammatory bowel diseases.
about
Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors.Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe.Biological and steroid use in relationship to quality measures in older patients with inflammatory bowel disease: a US Medicare cohort study.Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.Value-based health care for inflammatory bowel diseases.Indian Society of Gastroenterology consensus statements on Crohn's disease in India.Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.Value redefined for inflammatory bowel disease patients: a choice-based conjoint analysis of patients' preferences.Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.Targeted Physician Education and Standardizing Documentation Improves Documented Reporting with Inflammatory Bowel Disease Quality Measures in a Large Academic and Private Practice.Validation of Neutrophil CD64 Blood Biomarkers to Detect Mucosal Inflammation in Pediatric Crohn's Disease.Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease.Use of telemedicine in inflammatory bowel disease: a real monitoring option?
P2860
Q33624763-3A447852-4DF9-4EEA-858A-BAE7AB0CD27FQ35069447-3ECC11F7-088E-4A84-85E9-B5A50E4218D8Q36038958-DC34BC2E-907E-46E7-B578-76DD5EBBC4A1Q36192570-F465DBBE-FAF6-4129-832D-C4A9C1A7F46EQ37118397-C28A465E-5590-4997-B10D-CF49959C4CEFQ38357567-004F5489-5FC2-4056-8023-501676B5D7BDQ38378837-3CFDC3EF-5C20-4298-8F5D-EEF5F17E60F3Q38735146-97FD0B2D-9465-45B4-A079-838C121CCA9FQ39052281-B88CC959-60FA-421C-8A9E-CF14E897231BQ46772849-106E04C0-B478-48E6-8648-5E1EF34489D1Q47100161-CBC0A240-4D04-48B4-993C-E0282AEF8893Q47581081-17BEFD74-5F6C-49F8-9808-9FAAF4FFA2D7Q49616319-F7C0A242-EA62-433E-8C8F-2CB8F0A128C7Q50037387-463F6005-F008-4176-8CAC-4A94F6773095Q51295017-629D96F5-78DC-490D-9ED4-26ACEF06C1AD
P2860
A nationwide 2010-2012 analysis of U.S. health care utilization in inflammatory bowel diseases.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A nationwide 2010-2012 analysi ...... n inflammatory bowel diseases.
@en
A nationwide 2010-2012 analysi ...... n inflammatory bowel diseases.
@nl
type
label
A nationwide 2010-2012 analysi ...... n inflammatory bowel diseases.
@en
A nationwide 2010-2012 analysi ...... n inflammatory bowel diseases.
@nl
prefLabel
A nationwide 2010-2012 analysi ...... n inflammatory bowel diseases.
@en
A nationwide 2010-2012 analysi ...... n inflammatory bowel diseases.
@nl
P2093
P2860
P1476
A nationwide 2010-2012 analysi ...... in inflammatory bowel diseases
@en
P2093
Adriana Centeno
Belinda Wong-Swanson
Bennett E Roth
Christina Y Ha
Daniel Hollander
Daniel W Hommes
Eric Esrailian
Erin M McLaughlin
Jennifer M Choi
Jonathan Sack
P2860
P304
P356
10.1097/MIB.0000000000000139
P577
2014-10-01T00:00:00Z